• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

35th Annual Alton Ochsner Award Relating Smoking and Disease Awarded to Mount Sinai Physician

Article

Ochsner Health announced Paul J. Kenny, PhD as the 2020 recipient of the annual Alton Ochsner Award Relating Smoking and Disease, which recognizes scientific research achievements that provide major insights into the biological mechanisms relating tobacco smoking and human disease.

July 8, 2020—Ochsner Health, Louisiana's largest non-profit academic healthcare system, annouced Paul J. Kenny, PhD, as the recipient of the 35th annual Alton Ochsner Award Relating Smoking and Disease. Kenny is a Ward-Coleman professor and chair of the Nash Family Department of Neuroscience at the Icahn School of Medicine at Mount Sinai in new York.

The award is named after Alton Ochsner, MD, who, in 1939, published the first evidence indicating tobacco smoking was the makor cause of lung cancer. Kenny's research focused on nicotine addiction and provided insights for the development of new treatment methods. In particular, Kenny demonstrated the relevance of glucagon-like peptide to the regulation of nicotine craving.

"As our 2020 honoree, Dr. Kenny joins the ranks of other research giants in this field for his contributions studying nicotine addition,” said Leonardo Seoane, MD, chief academic officer of Ochsner Health.

Read the full press release here.

Related Videos
Pat Van Burkleo
Dr Padma Sripada, Columbia Internal Medicine
Pat Van Burkleo
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Joshua K. Sabari, MD< NYU Langone Perlmutter Cancer Center
dr marisa mcginley
Leslie Busby, MD, Rocky Mountain Cancer Centers
Camilla Levister
dr daniel ontaneda
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.